% | $
Quotes you view appear here for quick access.

Trius Therapeutics, AŞ Message Board

  • bioimmunomabman bioimmunomabman Jun 17, 2013 2:56 PM Flag

    VPHM money could move to TSRX

    VPHM acquisition potential could draw some new interest and capital to TSRX, they have an anti-bacterial medication. If acquired, $2BB in biopharma investment $, will need to find a new home, unless it's a stock for stock transaction with another antibiotic company and people decide to hold. A potential catalyst to watch.